These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 18024605)
21. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia. Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255 [TBL] [Abstract][Full Text] [Related]
22. Acute myeloid leukemia with severe aplastic anemia following immunosuppressive therapy. Bakhshi S; Gupta A; Kumar L Indian J Pediatr; 2006 Nov; 73(11):1033-5. PubMed ID: 17127787 [TBL] [Abstract][Full Text] [Related]
24. Aplastic anemia: therapeutic updates in immunosuppression and transplantation. Scheinberg P Hematology Am Soc Hematol Educ Program; 2012; 2012():292-300. PubMed ID: 23233595 [TBL] [Abstract][Full Text] [Related]
25. Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy. Arranz R; Otero MJ; Ramos R; Steegmann JL; Lamana ML; Tomás JF; de la Cámara R; Figuera A; Vázquez L; Fernádez-Rañada JM Bone Marrow Transplant; 1994 Apr; 13(4):383-7. PubMed ID: 8019461 [TBL] [Abstract][Full Text] [Related]
26. [Unrelated bone marrow transplantation in two severe aplastic anemia patients preconditioned with a regimen of cyclophosphamide, antithymocyte globulin, and total body irradiation]. Mizue N; Watanabe J; Katoh S; Oda T; Suzuki N; Kudoh T Rinsho Ketsueki; 1999 Mar; 40(3):213-7. PubMed ID: 10222628 [TBL] [Abstract][Full Text] [Related]
27. [Immune-mediated pathogenesis and management of pediatric aplastic anemia]. Huang YL; Huang SL Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):153-5. PubMed ID: 16624043 [No Abstract] [Full Text] [Related]
28. [Treatment of severe acquired aplastic anemia]. Jacobsen N Nord Med; 1995; 110(12):314-5. PubMed ID: 8524632 [TBL] [Abstract][Full Text] [Related]
29. Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings. Kobayashi R; Yabe H; Hara J; Morimoto A; Tsuchida M; Mugishima H; Ohara A; Tsukimoto I; Kato K; Kigasawa H; Tabuchi K; Nakahata T; Ohga S; Kojima S; Br J Haematol; 2006 Dec; 135(5):693-6. PubMed ID: 17038001 [TBL] [Abstract][Full Text] [Related]
30. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia. Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460 [TBL] [Abstract][Full Text] [Related]
32. Improved survival in severe acquired aplastic anemia of childhood. Fouladi M; Herman R; Rolland-Grinton M; Jones-Wallace D; Blanchette V; Calderwood S; Doyle J; Halperin D; Leaker M; Saunders EF; Zipursky A; Freedman MH Bone Marrow Transplant; 2000 Dec; 26(11):1149-56. PubMed ID: 11149724 [TBL] [Abstract][Full Text] [Related]
33. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults. Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461 [TBL] [Abstract][Full Text] [Related]
34. Audit of peripheral stem cell transplantation for aplastic anemia in multitransfused infected patients. Seth T; Kanga U; Sood P; Sharma V; Mishra P; Mahapatra M Transplant Proc; 2012 May; 44(4):922-4. PubMed ID: 22564586 [TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin. Kröger N; Zabelina T; Renges H; Krüger W; Kordes U; Rischewski J; Schrum J; Horstmann M; Ayuk F; Erttmann R; Kabisch H; Zander AR Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700 [TBL] [Abstract][Full Text] [Related]
37. Management of aplastic anemia: the role of systematic reviews and meta-analyses. Gafter-Gvili A; Ram R; Raanani P; Shpilberg O Acta Haematol; 2011; 125(1-2):47-54. PubMed ID: 21150187 [TBL] [Abstract][Full Text] [Related]
38. Immunosuppressive therapy versus bone marrow transplantation for children with aplastic anemia. Werner EJ; Stout RD; Valdez LP; Harris RE Pediatrics; 1989 Jan; 83(1):61-5. PubMed ID: 2642621 [TBL] [Abstract][Full Text] [Related]
39. Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation. Passweg JR; Marsh JC Hematology Am Soc Hematol Educ Program; 2010; 2010():36-42. PubMed ID: 21239768 [TBL] [Abstract][Full Text] [Related]
40. [Allogenic hematopoietic stem cell transplantation in acquired aplastic anemia: first experience of the National Center for Bone Marrow Grafting]. Abdelkefi A; Ladeb S; Ben Othman T; Torjman L; Jeddi R; Ben Abdeladhim A Tunis Med; 2001 Oct; 79(10):498-502. PubMed ID: 11910688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]